Poliovirus vaccine inactivated paediatric - GlaxoSmithKlineAlternative Names: IPV vaccine - GlaxoSmithKline; Poliorix
Latest Information Update: 13 Oct 2016
At a glance
- Originator GlaxoSmithKline
- Class Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Poliomyelitis
Most Recent Events
- 08 Jul 2010 GlaxoSmithKline completes a phase III trial (NCT01021293) in Poliomyelitis (prevention, in infants) in China